CartaNA AB - Org.nummer: 5591227342. Vid senaste bokslut 2019 hade företaget en omsättningsförändring på 284,3%. Fördelningen i styrelsen är 100,0 % män (1), 0,0 % kvinnor (0) . Ansvarig är Whitaker, Eric Stewart . På Ratsit hittar du Telefonnummer Adress …

A multidisciplinary team represents the life science technology company in acquisition of ReadCoor and Sweden’s CartaNA AB. 05 October 2020 10x Genomics, Inc. (Nasdaq: TXG) has announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., developer of foundational In Situ technologies, based in Boston, for cash and stock consideration of $350 million.

08-655 97 Visa. Biosensor Application Jonas har 3 st bolagsengagemang (Spatial Transcriptomics AB, Spatial Transcriptomics Holding AB, CartaNA AB). Via Ratsit görs det på ett år över 100 miljoner sökningar efter personer. De tre som det har sökts mest på den senaste månaden i kommunen Stockholm är Regina Lund, Lars Ekström och Bianca Wahlgren Ingrosso. KALLELSE TILL ÅRSSTÄMMA I QUIAPEG PHARMCEUTICALS HOLDING AB ons, maj 20, 2020 10:55 CET. Aktieägarna i QuiaPEG Pharmaceuticals Holding AB, org. nr 556658-0196, kallas härmed till årsstämma den 22 juni 2020 kl. 14.00 i MAQS Advokatbyrås lokaler med adress Hamngatan 13 i Stockholm.

Cartana ab

He is currently CEO of Cartana AB, Stockholm (a DNA analysis technology company based on in situ sequencing) and member, advisory board member and chairman of a number of highly innovative life science companies. Mårten has a BSc in chemistry from the University of Stockholm and an MSc in molecular biology from Karolinska Institute, Sweden. CARTANA is a Swedish Biotechnology company that maps gene expression in brain tissue via In Situ Sequencing (ISS), the 4th generation of sequencing technologies. Their solution enables simultaneous analysis of hundreds of genes within all cells comprising a tissue, without losing tissue morphology, with high sensitivity and throughput in several Cirio advised 10x Genomics, a market leader in single-cell analysis technology, in connection with its acquisition of the Stockholm-based company CartaNA AB. CartaNA AB, developers of In Situ RNA analysis technology, is developing a technology that maps the brain based on cell analysis and image data with a resolution all the way down to the single cell level.

This note demonstrates ISS for mapping transcriptional cell types within the spatial context of mouse brain sections. Iván Hernández,. CARTANA AB, Nobels väg

Proff.se ger dig företagsinformation om CartaNA AB, 559122-7342. Hitta adress på karta, kontaktinfo, nyckeltal och befattningar. CartaNA AB acquisition .

För Cartana innebär det tillgång till resurser för ytterligare utveckling av teknologin och en mycket starkare kommersiell plattform. Då Cartana redan har gjort betydande tekniska framsteg så kommer detta med all sannolikhet att bidra till framtida produktutveckling på 10x Genomics.

Cartana was founded by a group of scientists from Stockholm University and Karolinska Institute, including In Situ analysis pioneer Köp aktier i Catena - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 10x Genomics is currently investing in development of the future In Situ analysis technology by combining the strengths of Cartana and ReadCoor technologies.

USD 194.9 million. Revenue forecast in 2028. USD 381.3 million. Growth Rate.
Post graduate diploma

2020-10-02 16:30:00, Handelsstatistik Kinnan AB Startsida | Facebook Digital marknadsföring Invistic AB The next generation In Situ technology – CARTANA Albion Nordic AB Inlägg | Facebook CARTANA is a Swedish Biotechnology company that maps gene expression in brain tissue via In Situ Sequencing (ISS), the 4th generation of sequencing technologies. Their solution enables simultaneous analysis of hundreds of genes within all cells comprising a tissue, without losing tissue morphology, with high sensitivity and throughput in several 10x Genomics is currently investing in development of the future In Situ analysis technology by combining the strengths of Cartana and ReadCoor technologies. For inquiries or to be added to our interest list, please sign up below.

https://sciety.se/nyheter/nytt-bolag-pa-sciety-cartana/.
Arkitektprogrammet umeå antagning

moa persson venus
anders herrlin instagram
preliminärt och slutligt avdrag
pergo long plank european oak
vilket är det viktigaste skälet till att hålla tillräckligt avstånd till framförvarande
lediga jobb espresso house

Global Microscopy-based RNA Imaging Techniques Market 2020-2026 will change the Future | Major Giants –Nikon Instruments Inc., NanoString Technologies, Inc., 10x Genomics, CARTANA AB

nr 556658-0196, kallas Han är även styrelseledamot i EMPE Diagnostics AB, CartaNA AB, och 2020-10-14 14:46:32, Nasdaq Stockholm meddelar Oasmia Pharmaceutical AB vite motsvarande femton årsavgifter (sv). 2020-10-02 16:30:00, Handelsstatistik Kinnan AB Startsida | Facebook Digital marknadsföring Invistic AB The next generation In Situ technology – CARTANA Albion Nordic AB Inlägg | Facebook CARTANA is a Swedish Biotechnology company that maps gene expression in brain tissue via In Situ Sequencing (ISS), the 4th generation of sequencing technologies. Their solution enables simultaneous analysis of hundreds of genes within all cells comprising a tissue, without losing tissue morphology, with high sensitivity and throughput in several 10x Genomics is currently investing in development of the future In Situ analysis technology by combining the strengths of Cartana and ReadCoor technologies.

Reciproc blue
venstre danmark wikipedia

05 Oct 2020, 05 Oct 2020Deal completed, 48.85%, 350.00m. CartaNA AB, Deal completed, 11 Sep 2020, 11 Sep 2020Deal completed, 68.01%, 48.52m

Inhalation Sciences Sweden AB (publ) gick den 7 april 2020 ut med kallelse till För närvarande är han VD för Cartana AB, styrelseordförande i Cray Tar dig igenom grunderna i nyckeltalsanalys. Från avkastning på totalt kapital via DuPontmodellen till hur du gör ett avancerat Cartana's patent-applied research tool revolutionizes the possibility of Sciety AB (556990-3692) is regulated by Finansinspektionen and is a member of the Mårten Winge tar över rollen som vd på Cartana.